CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Donepezildrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00182884
NCT00182884Phase 4Completed
CompareCT.gov

Preventing Delirium in Hospitalized Elderly

Indiana University Health·interventional·Posted Sep 16, 2005·Updated Mar 3, 2008

In Brief

A Phase 4 clinical trial evaluating Donepezil for Postoperative Complications and Delirium. Completed, across 1 site.

Detailed Summary

The purpose of this study is to explore the efficacy of a perioperative daily dose of Donepezil (a cholinergic enhancer) in reducing the incidence and severity of delirium.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Complications, Delirium
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartJul 1, 2004
Primary CompletionApr 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 20.8 years ago

Interventions

Donepezildrug